Endothelial cells have been described to inhibit tumor immunity by downregulating molecules required for T-cell extravasation, by upregulating inhibitory receptors on T cells and by inducing T-cell apoptosis through TRAIL and FasL55,56. This evidence concerns the gene TNFSF10 and neoplasm.